Introduction to graft-versus-host disease
Open Access
- 28 February 2005
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (2) , 17-20
- https://doi.org/10.1016/j.bbmt.2004.11.009
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsThe Lancet, 2004
- Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseBlood, 2002
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trialBlood, 1989
- Risk factors for acute graft‐versus‐host diseaseBritish Journal of Haematology, 1987
- Graft‐versus‐Host Disease in Dog and Man: The Seattle ExperienceImmunological Reviews, 1985
- Graft-versus-host disease: pathophysiological and clinical aspects.Annual Review of Medicine, 1984
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionBlood, 1981
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974